Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Minkang Medical Technology is a leading Chinese medical device company specializing in the development and commercialization of biosensing technologies for chronic disease management, particularly diabetes. The company offers a comprehensive suite of products including traditional blood glucose monitoring (BGM) systems and advanced continuous glucose monitoring (CGM) solutions. Minkang's technology is built upon robust electrochemical and photochemical platforms, enabling high-precision testing for glucose, uric acid, ketones, and blood lipids. Headquartered in Beijing with significant manufacturing facilities in Tianjin and Zhejiang, the company serves both domestic and international markets. Minkang is positioned as a key innovator in the digital health space, integrating hardware with mobile health applications to provide holistic metabolic monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Minkang Medical Technology.